# GW Pharmaceuticals Plc (GWPH)

Source: https://www.quantisnow.com/company/GWPH
Generated: 2026-11-20T06:06:43.507Z

- Ticker: GWPH
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Major Pharmaceuticals
- IPO year: 2013

## Latest GWPH news and filings

- 2024-09-18 10:00 UTC [Leadership Update] [IDEAYA Biosciences Appoints Douglas B. Snyder as Senior Vice President, General Counsel](https://www.quantisnow.com/insight/ideaya-biosciences-appoints-douglas-b-snyder-as-senior-vice-president-5697408)
- 2023-01-05 22:45 UTC [Market Insight] [Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court](https://www.quantisnow.com/insight/jazz-pharmaceuticals-files-patent-infringement-against-generic-drugmakers-in-new-3880518)
- 2021-12-15 21:43 UTC [Market Insight] [Study Suggests Whole-Plant Medicinal Cannabis Could Be More Effective Than CBD In Epilepsy Treatment](https://www.quantisnow.com/insight/study-suggests-whole-plant-medicinal-cannabis-could-be-more-effective-than-2147072)
- 2021-05-17 10:09 UTC [SEC Form 15-12B] [SEC Form 15-12B filed by GW Pharmaceuticals Plc](https://www.quantisnow.com/insight/sec-form-15-12b-filed-by-gw-pharmaceuticals-plc-747218)
- 2021-05-07 20:25 UTC [SEC Form 4] [SEC Form 4: Tovey Christopher J. returned 2,496 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-tovey-christopher-j-returned-2496-units-of-717931)
- 2021-05-07 20:21 UTC [SEC Form 4] [SEC Form 4: Cline Darren S returned 5,556 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-cline-darren-s-returned-5556-units-of-717886)
- 2021-05-07 20:19 UTC [SEC Form 4] [SEC Form 4 filed by GRYSKA DAVID W](https://www.quantisnow.com/insight/sec-form-4-filed-by-gryska-david-w-717846)
- 2021-05-07 20:15 UTC [SEC Form 4] [SEC Form 4: Giacobello Scott M. returned 165,108 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-giacobello-scott-m-returned-165108-units-of-717765)
- 2021-05-07 20:15 UTC [SEC Form 4] [SEC Form 4: Secor Alicia returned 10,584 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-secor-alicia-returned-10584-units-of-ordinary-717764)
- 2021-05-07 20:15 UTC [SEC Form 4] [SEC Form 4: Knappertz Volker returned 92,412 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-knappertz-volker-returned-92412-units-of-ordinary-717763)
- 2021-05-07 20:15 UTC [SEC Form 4] [SEC Form 4: MACKEY CATHERINE J returned 10,536 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-mackey-catherine-j-returned-10536-units-of-717762)
- 2021-05-07 20:15 UTC [SEC Form 4] [SEC Form 4: Noble James returned 27,492 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-noble-james-returned-27492-units-of-ordinary-717761)
- 2021-05-07 20:15 UTC [SEC Form 4] [SEC Form 4: Gover Justin D. returned 2,546,129 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-gover-justin-d-returned-2546129-units-of-717759)
- 2021-05-07 20:15 UTC [SEC Form 4] [SEC Form 4: Snyder Douglas B. returned 61,848 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-snyder-douglas-b-returned-61848-units-of-717754)
- 2021-05-07 20:15 UTC [SEC Form 4] [SEC Form 4: Brown Cabot returned 7,200 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-brown-cabot-returned-7200-units-of-ordinary-717741)
- 2021-05-07 20:15 UTC [SEC Form 4] [SEC Form 4: GUY GEOFFREY W DR returned 4,910,446 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-guy-geoffrey-w-dr-returned-4910446-units-717735)
- 2021-05-07 20:15 UTC [SEC Form 4] [SEC Form 4 filed by Waldegrave William A.](https://www.quantisnow.com/insight/sec-form-4-filed-by-waldegrave-william-a-717726)
- 2021-05-05 21:27 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by GW Pharmaceuticals Plc](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-gw-pharmaceuticals-plc-704429)
- 2021-05-05 21:26 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by GW Pharmaceuticals Plc](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-gw-pharmaceuticals-plc-704401)
- 2021-05-05 21:25 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by GW Pharmaceuticals Plc](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-gw-pharmaceuticals-plc-704382)
- 2021-05-05 21:24 UTC [SEC Form POSASR filed by GW Pharmaceuticals Plc](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-gw-pharmaceuticals-plc-704376)
- 2021-05-05 21:23 UTC [SEC Form 8-K] [GW Pharmaceuticals Plc filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/gw-pharmaceuticals-plc-filed-sec-form-8-k-completion-of-acquisition-704358)
- 2021-05-05 13:15 UTC [Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc](https://www.quantisnow.com/insight/jazz-pharmaceuticals-completes-acquisition-of-gw-pharmaceuticals-plc-700028)
- 2021-05-05 12:54 UTC [SEC Form 25-NSE filed by GW Pharmaceuticals Plc](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-gw-pharmaceuticals-plc-699594)
- 2021-04-30 21:01 UTC [SEC Form 10-K] [SEC Form 10-K/A filed by GW Pharmaceuticals Plc (Amendment)](https://www.quantisnow.com/insight/sec-form-10-ka-filed-by-gw-pharmaceuticals-plc-amendment-681670)
- 2021-04-29 00:00 UTC [GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen's Award for Enterprise in Innovation](https://www.quantisnow.com/insight/gw-pharmaceuticals-recognised-for-leadership-in-prescription-cannabis-based-medicines-with-668702)
- 2021-04-24 01:27 UTC [SEC Form 8-K] [GW Pharmaceuticals Plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/gw-pharmaceuticals-plc-filed-sec-form-8-k-submission-of-matters-650679)
- 2021-04-23 20:01 UTC [GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals](https://www.quantisnow.com/insight/gw-pharmaceuticals-shareholders-approve-acquisition-by-jazz-pharmaceuticals-649041)
- 2021-04-20 13:14 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by GW Pharmaceuticals Plc](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-gw-pharmaceuticals-plc-633842)
- 2021-04-20 13:10 UTC [SEC Form 8-K] [GW Pharmaceuticals Plc filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/gw-pharmaceuticals-plc-filed-sec-form-8-k-other-events-633810)
- 2021-04-20 13:05 UTC [SEC Form DFAN14A] [SEC Form DFAN14A filed by GW Pharmaceuticals Plc](https://www.quantisnow.com/insight/sec-form-dfan14a-filed-by-gw-pharmaceuticals-plc-633786)
- 2021-04-20 10:30 UTC [GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex](https://www.quantisnow.com/insight/gw-pharmaceuticals-receives-european-commission-approval-for-epidyolex-cannabidiol-for-632173)
- 2021-04-14 21:03 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by GW Pharmaceuticals Plc](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-gw-pharmaceuticals-plc-618186)
- 2021-04-14 21:03 UTC [SEC Form 8-K] [GW Pharmaceuticals Plc filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/gw-pharmaceuticals-plc-filed-sec-form-8-k-other-events-618182)
- 2021-04-13 12:30 UTC [GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual Meeting](https://www.quantisnow.com/insight/gw-pharmaceuticals-and-us-subsidiary-greenwich-biosciences-to-present-data-611313)
- 2021-04-09 00:00 UTC [SEC Form 4] [SEC Form 4: B. Douglas Snyder sold $152,208 worth of Ordinary Shares (8,400 units at $18.12), decreasing direct ownership by 12% to 61,848 units](https://www.quantisnow.com/insight/sec-form-4-b-douglas-snyder-sold-152208-worth-of-602453)
- 2021-03-31 00:00 UTC [SEC Form 4] [SEC Form 4: Volker Knappertz sold $55,386 worth of Ordinary Shares (3,060 units at $18.10), decreasing direct ownership by 3% to 92,412 units](https://www.quantisnow.com/insight/sec-form-4-volker-knappertz-sold-55386-worth-of-ordinary-568932)
- 2021-03-25 21:06 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by GW Pharmaceuticals Plc](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-gw-pharmaceuticals-plc-554714)
- 2021-03-23 20:38 UTC [SEC Form DFAN14A] [SEC Form DFAN14A filed by GW Pharmaceuticals Plc](https://www.quantisnow.com/insight/sec-form-dfan14a-filed-by-gw-pharmaceuticals-plc-545179)
- 2021-03-23 20:06 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by GW Pharmaceuticals Plc](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-gw-pharmaceuticals-plc-544825)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/GWPH
- Earnings history: https://www.quantisnow.com/earnings/GWPH
- Dividend history: https://www.quantisnow.com/dividends/GWPH
- Insider transactions: https://www.quantisnow.com/insiders/GWPH
- Options chain: https://www.quantisnow.com/options/GWPH
- SEC 8-K filings only: https://www.quantisnow.com/company/GWPH/8-k
- RSS and alerts for GWPH: https://www.quantisnow.com/docs/rss-feeds.md
